Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark.
DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark.
Scand J Rheumatol. 2020 Jan;49(1):1-7. doi: 10.1080/03009742.2019.1637932. Epub 2019 Sep 20.
: The Stanford Health Assessment Questionnaire Disability Index (HAQ-DI) is a widely used patient-reported outcome for functional disability in rheumatoid arthritis (RA). Minimal clinically important differences (MCIDs) in the HAQ-DI were previously calculated based on device-corrected ordinal HAQ-DI scores, leading to limited generalizability and validity for today's patients. Our objectives were to examine the internal construct validity of the unadjusted HAQ-DI and to determine an MCID in a cohort of Danish RA patients based on the transformed linear logit scale of the HAQ-DI.: The study included 362 RA patients registered in the DANBIO registry. The Rasch model was fitted to HAQ-DI data at baseline and after 3 months' follow-up. MCID was calculated as the median changes in the original HAQ-DI score and logit HAQ-DI score in those patients who had experienced minimal improvement (15-30 mm on a 0-100 mm Patient Global scale).: HAQ-DI data showed acceptable fit to the Rasch model at both time-points, and consistent item ranking across time indicated instrument invariance. Sixty-one patients (16.8%, ~1/6) had an improvement above the MCID on the logit scale but improvement below the MCID on the original scale, while the opposite was not the case for any patients.: The Danish unadjusted version of the HAQ-DI showed acceptable internal construct validity. Application of the logit MCID classified an additional one in six patients as having achieved an MCID compared to the MCID calculated on the ordinal scale, which may have potential implications for the powering of future studies.
斯坦福健康评估问卷残疾指数(HAQ-DI)是一种广泛用于评估类风湿关节炎(RA)患者功能障碍的患者报告结局。HAQ-DI 的最小临床重要差异(MCID)之前是基于设备校正的有序 HAQ-DI 评分计算的,这导致其在今天的患者中具有有限的通用性和有效性。我们的目的是检验未经调整的 HAQ-DI 的内部结构效度,并根据 HAQ-DI 的转换线性逻辑量表在丹麦 RA 患者队列中确定 MCID。
该研究纳入了登记在 DANBIO 注册中心的 362 名 RA 患者。在基线和 3 个月随访时,HAQ-DI 数据拟合了 Rasch 模型。MCID 计算为在那些经历最小改善(患者总体评分为 0-100mm 时为 15-30mm)的患者中,原始 HAQ-DI 评分和逻辑 HAQ-DI 评分的中位数变化。
HAQ-DI 数据在两个时间点均符合 Rasch 模型的要求,并且随着时间的推移,项目的排序一致,表明仪器具有不变性。61 名患者(16.8%,约 1/6)在逻辑量表上的改善超过 MCID,但在原始量表上的改善低于 MCID,而对于任何患者都没有出现相反的情况。
丹麦未经调整的 HAQ-DI 版本显示出可接受的内部结构效度。与在有序量表上计算的 MCID 相比,应用逻辑 MCID 将另外六分之一的患者归类为达到 MCID,这可能对未来研究的效力产生影响。